Guidance for industry. Safety testing of drug metabolites; Center for Drug Evaluation and Research: Rockville, MD, USA, 2008.
Guidance for industry. Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals., 2010.
Questions and answers (R2) on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. 2013.
Gad, S.C. Preclinical development handbook: ADME and biopharmaceutical properties; John Wiley & Sons: New York, 2008.
Bryant, B.; Knights, K. Pharmacology for Health Professionals ebook; Elsevier Health Sciences: Amsterdam, 2014.
Wang, Z.; Smart, R.; Hodgson, E. Molecular and biochemical toxicology; John Wiley & Sons, Inc.: New York, 2007.
Sun, Q.; Zhu, R.; Foss, F.W., Jr; Macdonald, T.L. In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity. Chem. Res. Toxicol., 2018, 21(3), 711-719.
Kadi, A.A. Attwa, Mohamed W.; Darwish, H.W. LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways. RSC Advances, 2018, 8(3), 1182-1190.
Arisawa, A.; Agematu, H. A modular approach to biotransformation using microbial cytochrome P450 monooxygenases. Modern Biooxid.: Enzym. React. Appl., 2007, 2007, 177-192.
Jurva, J.U. Electrochemistry on-line with mass spectrometry: Instrumental methods for in vitro generation and detection of drug
metabolites; Groningen: Netherlands. , 2004.